Last updated on October 2020

Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics


Brief description of study

The purpose of the study is to evaluate effect of benralizumab on structural and lung function changes in severe eosinophilic asthmatics.

Changes will be assessed over 48 week treatment period in patients with persistent symptoms despite standard therapy of inhaled corticosteroids (ICS) plus long acting B2-agonist (LABA) with or without additional controller medication.

Patients who complete treatment will enter 4 weeks follow-up period.

Clinical Study Identifier: NCT03953300

Find a site near you

Start Over

Research Site

Los Angeles, CA United States
  Connect »

Research Site

Aurora, CO United States
  Connect »

Research Site

New Haven, CT United States
  Connect »

Research Site

Decatur, GA United States
  Connect »

Research Site

Iowa City, IA United States
  Connect »

Research Site

Baltimore, MD United States
  Connect »

Research Site

Ann Arbor, MI United States
  Connect »

Research Site

Kansas City, MO United States
  Connect »

Research Site

Saint Louis, MO United States
  Connect »

Research Site

Durham, NC United States
  Connect »

Research Site

Greenville, NC United States
  Connect »

Research Site

New Bern, NC United States
  Connect »

Research Site

Winston-Salem, NC United States
  Connect »

Research Site

Philadelphia, PA United States
  Connect »

Research Site

Pittsburgh, PA United States
  Connect »

Research Site

Galveston, TX United States
  Connect »

Research Site

Calgary, AB Canada
  Connect »

Research Site

Edmonton, AB Canada
  Connect »

Research Site

Hamilton, ON Canada
  Connect »

Research Site

Aarhus N, Denmark
  Connect »

Research Site

Hvidovre, Denmark
  Connect »

Research Site

København NV, Denmark
  Connect »

Research Site

Naestved, Denmark
  Connect »

Research Site

Odense C, Denmark
  Connect »

Research Site

Ålborg, Denmark
  Connect »

Research Site

Göteborg, Sweden
  Connect »

Research Site

Liverpool, United Kingdom
  Connect »

Research Site

London, United Kingdom
  Connect »

Research Site

Oxford, United Kingdom
  Connect »

Research Site

Boston, MA United States
  Connect »

Research Site

København NV, Denmark
  Connect »

Research Site

Ålborg, Denmark
  Connect »

Research Site

Göteborg, Sweden
  Connect »

Research Site

København NV, Denmark
  Connect »

Research Site

Ålborg, Denmark
  Connect »

Research Site

Göteborg, Sweden
  Connect »

Research Site

København NV, Denmark
  Connect »

Research Site

Ålborg, Denmark
  Connect »

Research Site

Göteborg, Sweden
  Connect »

Research Site

København NV, Denmark
  Connect »

Research Site

Ålborg, Denmark
  Connect »

Research Site

Göteborg, Sweden
  Connect »

Research Site

København NV, Denmark
  Connect »

Research Site

Ålborg, Denmark
  Connect »

Research Site

Göteborg, Sweden
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.